CD24 and neoplasm: Anti-CD24 monoclonal antibodies have also been conjugated with Pseudomonas-derived exotoxin; this approach produced dose-dependent cytotoxicity in CD24-expressing colorectal cancer cells and inhibited tumor growth in xenograft models, with the results replicated in a second preclinical study [45,112].